Kanglong Chemical (03759) expects net profit to be increased by 4% to 10% year-on-year in the first half of the year

According to the Zhitong Finance App, Kanglong Chemical (03759) announced that it expects to obtain operating income of 7.47 billion yuan to 7.66 billion yuan in the 2026 semi-year, an increase of 16% to 19% over the same period of the previous year; net profit attributable to shareholders of listed companies was 729 million yuan to 772 million yuan, an increase of 4% to 10% over the same period last year.

In the first half of 2026, along with the continuous expansion of the company's strategic customers and the continuous advancement of the small-molecule CDMO service project pipeline, the company's new orders increased by more than 30% year-on-year; among them, new orders for laboratory services increased by more than 20% year-on-year, and new orders for small-molecule CDMO services increased by more than 50% year-on-year. The company continues to increase talent introduction efforts and expand R&D and production service teams to meet rapidly growing business needs.